These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8239479)

  • 21. Fibrinolytic activity in Nigerian diabetics.
    Adediran IA; Ikem RT; Borisade MF
    Postgrad Med J; 2004 Oct; 80(948):610-2. PubMed ID: 15466998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inactivation of plasminogen activator inhibitor type 1 by activated factor XII plays a role in the enhancement of fibrinolysis by contact factors in-vitro.
    Tanaka A; Suzuki Y; Sugihara K; Kanayama N; Urano T
    Life Sci; 2009 Jul; 85(5-6):220-5. PubMed ID: 19500599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of actomyosin on blood coagulation and fibrinolysis].
    Andreenko GV; Liutova LV
    Vopr Med Khim; 1976; 22(2):166-71. PubMed ID: 1030884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resistance of porcine blood clots to lysis relates to poor activation of porcine plasminogen by tissue plasminogen activator.
    Flight SM; Masci PP; Lavin MF; Gaffney PJ
    Blood Coagul Fibrinolysis; 2006 Jul; 17(5):417-20. PubMed ID: 16788320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.
    Rość D; Kremplewska-Nalezyta E; Gadomska G; Zastawna E; Michalski A; Drewniak W
    Med Sci Monit; 2000; 6(4):684-91. PubMed ID: 11208392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [An evaluation of euglobulin clot lysis time (ELT) measurement with the time saving recorder (author's transl)].
    Amemiya Y; Amaki I; Ariga T; Sawai H; Oshiba S
    Rinsho Ketsueki; 1973 Oct; 14(10):1008-17. PubMed ID: 4796985
    [No Abstract]   [Full Text] [Related]  

  • 27. Depletion of plasminogen in vitro or during thrombolytic therapy limits fibrinolytic potential.
    Onundarson PT; Francis CW; Marder VJ
    J Lab Clin Med; 1992 Jul; 120(1):120-8. PubMed ID: 1613318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The euglobulin clot lysis time, a rapid and sensitive method for the assay of fibrinolytic activity after venous stasis.
    Nordby E; Arnesen H; Andersen P; Godal HC
    Scand J Haematol; 1980 Nov; 25(5):407-11. PubMed ID: 7221476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of euglobulin clot lysis time as a screening method for determination of blood plasma fibrinolytic activity after venous occlusion.
    Boberg M; Killander A
    Acta Med Scand; 1983; 213(4):309-11. PubMed ID: 6613690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The euglobulin lysis time test: an ineffectual monitor of the therapeutic inhibition of fibrinolysis.
    Katz J; Lurie A; Becker D; Metz J
    J Clin Pathol; 1970 Sep; 23(6):529-32. PubMed ID: 4991001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Fibrinolytic system in bronchial asthma after prednisone treatment].
    Banach-Wawrzeńczyk E; Dziedziczko A; Rość D
    Pol Merkur Lekarski; 2000 Jan; 7(43):9-11. PubMed ID: 10765644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of vegetarianism on fibrinolytic activity.
    Ho CH; Chwang LC
    Proc Natl Sci Counc Repub China B; 1993 Jan; 17(1):35-9. PubMed ID: 8234542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Euglobulin lysis time].
    Sakuragawa N
    Nihon Rinsho; 1997 Mar; 55 Suppl 1():139-44. PubMed ID: 9097575
    [No Abstract]   [Full Text] [Related]  

  • 34. Absence of synergism between tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (scu-PA) and urokinase on clot lysis in a plasma milieu in vitro.
    Collen D; De Cock F; Demarsin E; Lijnen HR; Stump DC
    Thromb Haemost; 1986 Aug; 56(1):35-9. PubMed ID: 3095946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of concomitant thrombin-mediated fibrin formation enhances clot lysis in whole blood.
    Haskel EJ; Eisenberg PR; Abendschein DR
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):7-13. PubMed ID: 8457655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibrinolytic activity in children with Plasmodium falciparum malaria.
    Omoigberale AI; Abiodun PO; Famodu AA
    East Afr Med J; 2005 Feb; 82(2):103-5. PubMed ID: 16122100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Fibrinolysis].
    Levy G; Michault A; Jamet M
    Ann Anesthesiol Fr; 1978; 19(8):703-8. PubMed ID: 31114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma TAFI levels influence the clot lysis time in healthy individuals in the presence of an intact intrinsic pathway of coagulation.
    Mosnier LO; von dem Borne PA; Meijers JC; Bouma BN
    Thromb Haemost; 1998 Nov; 80(5):829-35. PubMed ID: 9843179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Studies on the ratio of the euglobulin clot lysis time and fibrinogen content in euglobulin (author's transl)].
    Matsuo T; Matsunaga K
    Rinsho Ketsueki; 1974 Oct; 15(10):1128-32. PubMed ID: 4476809
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of retraction on the lysis of human clots with fibrin specific and non-fibrin specific plasminogen activators.
    Sabovic M; Lijnen HR; Keber D; Collen D
    Thromb Haemost; 1989 Dec; 62(4):1083-7. PubMed ID: 2515603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.